Arnaud Robert Named Journalist of the Year at Swiss Press Award for Investigative Report and Podcast “Mon corps électrique”

When I first saw the headlines about Arnaud Robert winning Journalist of the Year at the Swiss Press Awards, my initial reaction wasn’t just about the award itself—it was about the profound human story beneath it. A journalist from Vevey, Switzerland, rendered tetraplegic after a mountain fall, choosing not to retreat but to document his journey into experimental neurosurgery through a podcast called “Mon corps électrique”? That’s the kind of narrative that doesn’t just stay in Lausanne or echo through Geneva’s Tribune de Genève offices—it reverberates in unexpected places, like the neurotech corridors of Boston’s Kendall Square or the rehab labs humming near Northwestern University in Chicago. And honestly? That’s where this hits closest to home for me, sitting here as someone who’s spent years tracking how medical breakthroughs move from lab bench to bedside in America’s heartland.

The source material is clear: after his accident, Robert was invited to join a clinical study at Lausanne’s CHUV (Centre Hospitalier Universitaire Vaudois) aimed at restoring arm mobility through cranial implants. His podcast doesn’t shy away from the tension—quoting him directly from the RTS coverage: “Reprendre le combat, passer entre les mains d’ingénieurs et de médecins, franchement, je n’en ai pas du tout envie. Pourtant, il y a au fond de moi quelque chose qui me hurle d’y aller.” That raw ambivalence—between fear of becoming a test subject and a deeper pull toward progress—is universal. It’s the same tension I’ve heard in focus groups at Shirley Ryan AbilityLab in Chicago, where patients weigh the promise of brain-computer interfaces against the loss of autonomy that comes with being wired into a machine. Robert’s story isn’t just Swiss; it’s a mirror for any community grappling with how far we push human enhancement.

What makes this journalistically significant isn’t just the subject—it’s the form. The Swiss Press Award jury specifically highlighted how his audio documentary uses sound to convey internal struggle, calling it a descent “into the land of cranial implants, the promise of miracle, and a disability discovered episode by episode.” That’s sophisticated storytelling. It reminds me of the operate coming out of WBEZ’s Curious City or Gimlet’s early narrative experiments—where audio isn’t just a medium but a tool for emotional archaeology. And critically, Robert isn’t some distant expert; he’s a former music journalist turned local freelancer in Romandy, much like the beat reporters I’ve known at Chicago Public Media who started covering indie shows at Lincoln Hall before moving into investigative units. His credibility comes from being embedded, not parachuted in.

Digging deeper, there’s a second-order effect here that often gets missed: how stories like Robert’s shape public understanding of clinical trials. The CHUV study he’s participating in isn’t abstract—it’s part of a global push in neuroprosthetics, with parallel trials running at Case Western Reserve’s FES Center in Cleveland and Pittsburgh’s Rehab Neural Engineering Labs. When a respected journalist like Robert documents his own participation with such candor—detailing both the hope and the frustration—it does something vital: it demystifies the process for ordinary people. I’ve seen this dynamic before during the early CAR-T therapy trials, where patient diaries published in Stat News helped shift public perception from “guinea pig experiments” to “courageous frontier medicine.” Robert’s podcast could do the same for neurotech.

Given my background in health technology policy, if this trend impacts you in Chicago—where institutions like Shirley Ryan AbilityLab, Northwestern’s Feinberg School of Medicine, and the Rehabilitation Institute of Chicago are actively involved in neurointerface research—here are the three types of local professionals you’d want to consult:

• Neurorehabilitation Specialists with Trial Navigation Experience: Look for clinicians who aren’t just versed in traditional PT/OT but have specific experience guiding patients through consent processes for implantable device trials. They should understand both the neurological metrics (like fMRI biomarkers for motor intent) and the psychosocial burdens—knowing when to push forward and when to pause for psychological support. The best ones often have dual appointments at academic hospitals and VA centers, bringing veteran-focused pragmatism to cutting-edge work.
• Biotech Ethics Consultants Familiar with Patient-Led Narratives: Seek advisors who’ve worked with Institutional Review Boards (IRBs) but as well value qualitative patient feedback as data—not just anecdote. They should know how to interpret tools like the Neuroethics Quality of Life Scale (NeuroQoL) and have facilitated patient advisory boards for early-feasibility studies. Bonus if they’ve collaborated with storytellers or documentary producers; Robert’s case shows why integrating narrative capture into trial design improves retention and informed consent.
• Assistive Technology Integrators with Open-Source Leanings: Identify specialists who prioritize interoperability—those who work with platforms like OpenBCI or NeuroPace’s RNS system rather than locking patients into proprietary ecosystems. They should understand FDA’s Safer Technologies Program (STeP) pathways and have experience helping patients navigate insurance appeals for hybrid systems (where clinical-grade implants interface with consumer wearables for daily use). The ideal provider treats the device as part of a lifelong ecosystem, not a one-time surgical fix.

Ready to find trusted professionals? Browse our complete directory of top-rated neurotechnology specialists in the Chicago area today.